<DOC>
	<DOCNO>NCT02993510</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness use Chondro-Gide® collagen membrane either suture glued compare microfracture alone treatment symptomatic cartilage defect knee .</brief_summary>
	<brief_title>A Randomized Controlled Trial Comparing Chondro-Gide® Microfracture Alone Treatment Knee Cartilage Defects .</brief_title>
	<detailed_description>- Prospective , randomize , active treatment-controlled , open-label multicenter study ( 40 site US EU ) . - All subject meet preoperative screening eligibility criterion randomize treatment Chondro-Gide® either suture glued Microfracture alone . - Eligible consent subject randomize 1:1:1 ratio use centralize randomization list receive one follow treatment : Group I : Microfracture alone ; Group II : Microfracture cover Chondro-Gide® membrane glue fibrin glue ( AMIC glue ) ; Group III : Microfracture cover Chondro-Gide® membrane suture ( AMIC suture ) - All subject assess interval post-procedure ( 6 week , 3 month , 1,2 5 year ) . - Subjects require follow strict pre-specified post-surgery rehabilitation protocol specific defect location . - Measures assess effectiveness safety conduct follow-up . - Safety assess collection adverse event timepoints .</detailed_description>
	<mesh_term>Osteochondritis</mesh_term>
	<mesh_term>Osteochondritis Dissecans</mesh_term>
	<criteria>Male female 18 50 One two cartilage defect Grade III IV accord Outerbridge classification Defect size 2 10 cm2 ( inclusive ) Intact normal surround cartilage suture ChondroGide® membrane Informed consent Patient willing fulfill strict postoperative physiotherapy scheme More 2 defect Defects knee Xray sign osteoarthritis Bone lesion &gt; 0.7 cm defect Knee instability , varus valgus deformation , status complete meniscus resection , status mosaicplasty , patella dysplasia Rheumatoid , infectious disease Skin lesion operate knee Treatment cartilage build medication Drug alcohol abuse Chronic heart disease , endocrine metabolic disease , Haemophilia A/B Pregnancy lactation Collagen allergy Participation Trials</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>microfracture</keyword>
	<keyword>enhance marrow stimulation</keyword>
	<keyword>articular cartilage</keyword>
	<keyword>Autologous Matrix-Induced Chondrogenesis</keyword>
	<keyword>Chondro-Gide®</keyword>
	<keyword>knee surgery</keyword>
	<keyword>AMIC</keyword>
</DOC>